搜索





搜索





Summit Therapeutics Inc

SMMT

添加自选

17.550USD

+0.550+3.24%

收盘 09-11 16:00（美东）

13.93B总市值

亏损市盈率 TTM

盘后交易 16:50 (美东)17.630USD+0.105+0.60%

Summit Therapeutics Inc

17.550

+0.550+3.24%

财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

概览

新闻分析

财务

股票评分

技术分析

预测

持股情况

股息

公司资料

财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

SMMT 利润表

您可以在这里找到Summit Therapeutics Inc的年度或季度收入报告，以深入了解Summit Therapeutics Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

营业总收入

----

--0.00

----

--0.00

-100.00%0.00

-83.19%220.00K

312.28%235.00K

30.21%250.00K

35.68%251.00K

623.20%1.31M

-66.47%57.00K

-40.74%192.00K

--185.00K

--181.00K

--170.00K

--324.00K

营业收入

----

--0.00

----

--0.00

-100.00%0.00

-83.19%220.00K

312.28%235.00K

30.21%250.00K

35.68%251.00K

623.20%1.31M

-66.47%57.00K

-40.74%192.00K

--185.00K

--181.00K

--170.00K

--324.00K

营业费用

-61.21%220.50M

192.01%195.21M

241.73%224.93M

303.02%234.21M

1169.71%568.44M

56.92%66.85M

80.88%65.82M

179.97%58.11M

184.16%44.77M

153.87%42.60M

188.24%36.39M

12.91%20.76M

14.69%15.76M

-30.38%16.78M

-57.65%12.62M

-25.30%18.38M

-50.92%13.74M

15.92%24.10M

84.02%29.81M

30.75%24.61M

54.62%27.99M

81.96%20.79M

--16.20M

--18.82M

--18.10M

--11.43M

研发费用

-24.17%157.73M

158.69%132.62M

186.66%147.29M

247.51%131.10M

575.44%208.02M

66.05%51.27M

107.07%51.38M

146.19%37.72M

225.87%30.80M

212.38%30.87M

360.71%24.81M

-10.12%15.32M

4.92%9.45M

-51.92%9.88M

-76.69%5.39M

-14.51%17.05M

-62.35%9.01M

11.85%20.56M

87.94%23.11M

45.29%19.94M

76.27%23.92M

42.34%18.38M

--12.29M

--13.73M

--13.57M

--12.91M

折旧摊销及损耗

24.32%46.00K

76.00%44.00K

90.91%42.00K

110.00%42.00K

85.00%37.00K

-7.41%25.00K

-26.67%22.00K

-37.50%20.00K

-56.52%20.00K

-70.00%27.00K

-90.16%30.00K

-89.68%32.00K

-86.10%46.00K

-71.61%90.00K

-7.01%305.00K

-8.01%310.00K

-4.61%331.00K

-5.37%317.00K

-28.38%328.00K

-15.11%337.00K

-3.34%347.00K

-0.89%335.00K

--458.00K

--397.00K

--359.00K

--338.00K

其他营业费用

----

99.71%-1.00K

100.00%0.00

99.46%-12.00K

98.65%-42.00K

68.55%-340.00K

-325.93%-4.24M

-15.03%-2.20M

-75.76%-3.11M

43.11%-1.08M

43.14%-995.00K

-54.14%-1.92M

64.99%-1.77M

---1.90M

---1.75M

---1.24M

---5.06M

营业利润

61.21%-220.50M

-192.01%-195.21M

-241.73%-224.93M

-303.02%-234.21M

-1169.71%-568.44M

-56.92%-66.85M

-80.88%-65.82M

-179.97%-58.11M

-184.16%-44.77M

-153.87%-42.60M

-188.24%-36.39M

-14.28%-20.76M

-16.69%-15.76M

29.65%-16.78M

57.29%-12.62M

22.05%-18.16M

51.66%-13.50M

-15.78%-23.85M

-84.58%-29.55M

-25.00%-23.30M

-55.77%-27.93M

-85.54%-20.60M

---16.01M

---18.64M

---17.93M

---11.10M

净非营业利息收入（费用）

利息收入

----

--2.38M

--2.48M

----

利息费用

----

-100.00%0.00

-99.69%9.00K

-9.81%2.46M

23.34%3.10M

-62.52%3.12M

-26.97%2.90M

2131.15%2.72M

878.60%2.52M

5378.29%8.33M

4797.53%3.97M

--122.00K

28.50%257.00K

462.96%152.00K

--81.00K

----

--200.00K

--27.00K

----

出售证券收益

54.42%4.30M

46.98%5.79M

30.19%5.75M

-47.19%2.42M

19.19%2.78M

93.32%3.94M

1542.75%4.42M

1064.00%4.58M

-35.11%2.33M

-24.22%2.04M

106.55%269.00K

---475.00K

--3.60M

--2.69M

-92.46%-4.11M

----

-4053.70%-2.13M

----

--54.00K

----

特殊收入（费用）

----

--0.00

100.00%0.00

----

--0.00

----

---15.01M

100.00%0.00

--0.00

---520.91M

---8.47M

----

-100.00%0.00

100.00%0.00

----

--480.00K

---859.00K

----

-固定资产出售收益

--500.00K

----

其他非经营性收入（费用）

----

--5.79M

-100.00%0.00

----

---53.00K

----

100.96%1.00K

----

100.00%0.00

-100.00%0.00

-101.14%-104.00K

98.52%-64.00K

99.87%-5.00K

-54.33%417.00K

685.74%9.15M

-3725.66%-4.32M

-686.42%-3.82M

269.70%913.00K

312.80%1.16M

86.83%-113.00K

-326.32%-486.00K

-116.50%-538.00K

---547.00K

---858.00K

---114.00K

--3.26M

税前利润

61.87%-215.70M

-201.09%-189.42M

-256.91%-219.17M

-313.99%-231.79M

-834.38%-565.71M

-44.01%-62.91M

-67.12%-61.41M

-160.02%-55.99M

-312.48%-60.54M

91.95%-43.69M

-83.52%-36.74M

4.76%-21.53M

16.51%-14.68M

-2251.01%-542.92M

34.58%-20.02M

3.44%-22.61M

38.57%-17.58M

-9.10%-23.09M

-91.00%-30.61M

-15.01%-23.41M

-58.59%-28.62M

-169.88%-21.17M

---16.02M

---20.36M

---18.05M

---7.84M

所得税

----

-15.17%-205.00K

199.62%264.00K

-507.69%-159.00K

60.70%-213.00K

77.55%-178.00K

78.35%-265.00K

104.81%39.00K

68.04%-542.00K

77.39%-793.00K

67.92%-1.22M

80.73%-810.00K

53.90%-1.70M

-35.81%-3.51M

-45.89%-3.81M

-51.88%-4.20M

-115.27%-3.68M

---2.58M

---2.62M

---2.77M

---1.71M

除税后利润

61.87%-215.70M

-201.09%-189.42M

-258.11%-219.17M

-312.05%-231.79M

-836.84%-565.71M

-44.72%-62.91M

-67.37%-61.20M

-164.50%-56.25M

-310.31%-60.38M

91.98%-43.47M

-90.17%-36.57M

0.55%-21.27M

12.25%-14.72M

-2434.82%-542.38M

29.04%-19.23M

-9.11%-21.39M

31.31%-16.77M

-22.35%-21.40M

-101.60%-27.10M

-10.46%-19.60M

-59.80%-24.42M

-185.10%-17.49M

---13.44M

---17.74M

---15.28M

---6.13M

持续经营利润

61.87%-215.70M

-201.09%-189.42M

-258.11%-219.17M

-312.05%-231.79M

-836.84%-565.71M

-44.72%-62.91M

-67.37%-61.20M

-164.50%-56.25M

-310.31%-60.38M

91.98%-43.47M

-90.17%-36.57M

0.55%-21.27M

12.25%-14.72M

-2434.82%-542.38M

29.04%-19.23M

-9.11%-21.39M

31.31%-16.77M

-22.35%-21.40M

-101.60%-27.10M

-10.46%-19.60M

-59.80%-24.42M

-185.10%-17.49M

---13.44M

---17.74M

---15.28M

---6.13M

归属于母公司的净利润

61.87%-215.70M

-201.09%-189.42M

-258.11%-219.17M

-312.05%-231.79M

-836.84%-565.71M

-44.72%-62.91M

-67.37%-61.20M

-164.50%-56.25M

-310.31%-60.38M

91.98%-43.47M

-90.17%-36.57M

0.55%-21.27M

12.25%-14.72M

-2434.82%-542.38M

29.04%-19.23M

-9.11%-21.39M

31.31%-16.77M

-22.35%-21.40M

-101.60%-27.10M

-10.46%-19.60M

-59.80%-24.42M

-185.10%-17.49M

---13.44M

---17.74M

---15.28M

---6.13M

归属于普通股东的净利润

61.87%-215.70M

-201.09%-189.42M

-258.11%-219.17M

-312.05%-231.79M

-836.84%-565.71M

-44.72%-62.91M

-67.37%-61.20M

-164.50%-56.25M

-310.31%-60.38M

91.98%-43.47M

-90.17%-36.57M

0.55%-21.27M

12.25%-14.72M

-2434.82%-542.38M

29.04%-19.23M

-9.11%-21.39M

31.31%-16.77M

-22.35%-21.40M

-101.60%-27.10M

-10.46%-19.60M

-59.80%-24.42M

-185.10%-17.49M

---13.44M

---17.74M

---15.28M

---6.13M

基本每股收益

63.61%-0.28

-186.57%-0.24

-244.57%-0.29

-302.78%-0.31

-793.06%-0.76

-37.59%-0.09

-59.16%-0.08

-153.97%-0.08

-304.46%-0.09

95.68%-0.06

47.59%-0.05

78.82%-0.03

87.47%-0.02

-557.36%-1.43

64.08%-0.10

28.43%-0.14

37.52%-0.17

-3.32%-0.22

-57.39%-0.28

23.80%-0.20

-18.52%-0.27

-131.38%-0.21

---0.18

---0.26

---0.23

---0.09

稀释每股收益

63.61%-0.28

-186.57%-0.24

-244.57%-0.29

-302.78%-0.31

-793.06%-0.76

-37.59%-0.09

-59.16%-0.08

-153.97%-0.08

-304.46%-0.09

95.68%-0.06

47.59%-0.05

78.82%-0.03

87.47%-0.02

-557.36%-1.43

64.08%-0.10

28.43%-0.14

37.52%-0.17

-3.32%-0.22

-57.39%-0.28

23.80%-0.20

-18.52%-0.27

-131.38%-0.21

---0.18

---0.26

---0.23

---0.09

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Summit Therapeutics Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 SMMT 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Summit Therapeutics Inc 全年的净利润是多少？



Summit Therapeutics Inc 2025 财年净利润为 -1.08B。

Summit Therapeutics Inc 上一季度的净利润是多少？



Summit Therapeutics Inc 最近一个季度的净利润为 -215.70M。

Summit Therapeutics Inc 年度营业利润是多少？



Summit Therapeutics Inc 2025 财年的营业利润为 -1.09B。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。